RESEARCH ARTICLE
Determinants of Medication Adherence among Jordanian Patients with End-Stage Kidney Disease
Manal M. Al-Sutari1, *, Raghad H. Abdelkader2, Nour H. Ababneh3
Article Information
Identifiers and Pagination:
Year: 2023Volume: 17
E-location ID: e187443462212221
Publisher ID: e187443462212221
DOI: 10.2174/18744346-v16-e221226-2022-144
Article History:
Received Date: 27/8/2022Revision Received Date: 24/11/2022
Acceptance Date: 5/12/2022
Electronic publication date: 02/02/2023
Collection year: 2023
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Background:
End-stage kidney disease (ESKD) requires complex medical management. To ensure the success of the management plan, the patient’s adherence to medication is fundamental. However, adherence to medication is challenging for patients with ESKD.
Objective:
This study aimed to describe adherence to medication and identify demographic and clinical determinants in Jordanian patients with ESKD.
Methods:
Cross-sectional correlational design was employed using a sample of 188 patients with ESKD who attended hemodialysis units at five hospitals in Amman between March and June 2021. Medication adherence was measured using Morisky Medication Adherence Scale (MMAS).
Results:
The mean age of the participants was 50.9 years (SD=15.64), more than half of the participants 109 (58.0%) were males and a total of 115 (61.2%) participants were non-smokers. The mean score of the MMAS was 5.18 (SD=2.024), which indicates a high prevalence of inadequate adherence to medication. Younger age, longer duration of hemodialysis, and higher number of medications were risk factors for inadequate adherence to medication among patients with ESKD.
Conclusion:
ESKD patients who are younger, have a longer duration of hemodialysis, and use a higher number of medications should be targeted as they face medication adherence challenges. Those patients should be taken into consideration when planning and developing interventions to enhance medication adherence in patients with ESKD.
